Phase II

Type: Keyphrase
Name: Phase II
First reported 15 hours ago - Updated 3 hours ago - 5 reports

Hatchtech Announces Successful Results from Phase 2 Ovicidal Study

Specialty pharmaceutical company Hatchtech Pty Ltd today announced positive results from a Phase 2 clinical study evaluating the ovicidal efficacy of a single, 10 minute application of Xeglyze™ Lotion developed as a treatment for head lice infestatio ... [Published Yahoo! Finance UK and Ireland - 15 hours ago]
First reported 21 hours ago - Updated 4 hours ago - 2 reports

Celgene oral Crohn's drug impresses in Phase II

Shares in Celgene Corp have risen steadily following promising mid-stage data of its closely-watched Crohn’s disease drug mongersen.Ahead of a presentation tomorrow at the United European Gastroenterology Week in Vienna, an abstract on mongersen, also ... [Published Pharma Times - 20 hours ago]
First reported 7 hours ago - Updated 5 hours ago - 2 reports

Omeros halts a Phase II Huntington's trial over alarming rat results

Following the FDA's advice, Omeros ($OMER) has hit the brakes on a mid-stage human trial of its Huntington's disease treatment in light of data from a separate animal study, news that tanked the biotech's share value.The drug, OMS824, works by blocking ... [Published FierceBiotech - 5 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Midrand apartments for sale from R510k

A combination of prime location, affordable price ranges and thorough research has been pivotal in the success of the Birchfield apartment complex in Midrand, where Phase 1 has sold out completely and Phase 2 is selling out fast.Fisher says units in Phase ... [Published Property24 - 7 hours ago]
First reported Oct 20 2014 - Updated 9 hours ago - 2 reports

Jericho Oil closes $4.23-million placement

Mr. Allen Wilson reportsJERICHO OIL COMPLETES $4.23 MILLION STRATEGIC FINANCING WITH EXISTING SHAREHOLDERSJericho Oil Corp. has closed its non-brokered private placement financing previously announced on Oct. 9, 2014, by issuing 8,461,036 units at 50 ... [Published Stockwatch - Oct 20 2014]
First reported Oct 20 2014 - Updated 13 hours ago - 2 reports

USDA Awards Grants to Small Businesses for Ag Research

The USDA's National Institute of Food and Agriculture on Monday awarded more than $18 million in grants to small businesses for research and development that will lead to technological innovations for agriculture.NIFA awarded 100 grants through the Small ... [Published Farm Futures - 13 hours ago]
First reported Oct 20 2014 - Updated 22 hours ago - 4 reports

Norgine Release: Positive Results From Phase 2 Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy

/PRNewswire/ --Norgine B.V. today announced that the Phase II study of its novel, low volume bowel preparation, NER1006, presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology (ACG), Philadelphia, PA, has met its primary ... [Published BioSpace - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 2 reports

Blaze wins NCI funding for 'tumor paint' after successful dog study

Seattle-based Blaze Bioscience has nabbed a $1.5 million Small Business Innovation Research (SBIR) Phase II award from the National Cancer Institute (NCI) to continue researching its product, called Tumor Paint BLZ-100, which will be studied in people ... [Published FierceMedicalDevices - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 3 reports

Inland, PGGM Complete Purchase of Newport Pavilion Phase II

Joint Venture Scoops Up Second Phase of Grocery-Anchored Power Center for $23.6 Million Inland Real Estate Corp. (NYSE: ) and Dutch pension fund advisor PGGM closed last week on the second phase of Newport Pavilion in Newport, KY for $23.6 million in ... [Published CoStar Group - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 5 reports

Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting

Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting ... [Published Nasdaq - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 5 reports

Phase II Data in Crohn’s Disease for Celgene’s Oral Antisense Therapy GED-0301 to Be Presented at UEG Week 2014

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced that results from a double-blind, placebo-controlled, multicenter phase ... [Published Yahoo! Finance UK and Ireland - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 2 reports

RTA announces Phase II of Water Canal Project

Phase II of the Dubai Water Canal Project kicks offThe Roads and Transport Authority (RTA) is on its final stages of completion for Phase I of the main traffic diversion on Al Wasl Road nearby Safa Park. These preparations are needed for starting Phase ... [Published Travel Daily Media - Oct 20 2014]

Quotes

...with Novartis moving into the clinic in the months and years ahead," commented Marlies Sproll, chief scientific officer of MorphoSys, adding: "We are also very pleased that this is the third ophthalmology program within our collaboration to enter the clinical development stage."
"Program officials will evaluate system performance based upon telemetry and other data obtained during the test" MDA said
...Shaheen. "In addition to expert interviews, the research team conducted two kinds of surveys with bikesharing users. One was the online member survey sent to all individuals for whom the operator had an email address. The second survey was an on-street survey for anyone, including casual users – those who are not members of the system and use it on a short-term basis. These surveys were conducted on the street by way of a smartphone."

More Content

All (6854) | News (5522) | Reports (3) | Blogs (1118) | Audio/Video (0) | Fact Sheets (27) | Press Releases (154)
sort by: Date | Relevance
New light commercial vehicles in China, 2010: T... [Published International Council on Clean Transportation - 27 mins ago]
UK. Celebrating Phase ll at OysterYachts Wroxham [Published BYM News - 31 mins ago]
Semba gets $1.5 million grant [Published IB Madison - 41 mins ago]
With Latest Data, Investors Again Compare Syner... [Published Stock Nod - 44 mins ago]
Sex, Spice, and Small-Town Texas Justice: The P... [Published First Coast News - 1 hour ago]
With Latest Data, Investors Again Compare Syner... [Published Tamar Securities - 1 hour ago]
Neurotrope Tackles Alzheimer's Disease With Nov... [Published Seeking Alpha - 1 hour ago]
Sex, Spice, and Small-Town Texas Justice: The P... [Published REASON Online - 2 hours ago]
Area Briefing, Oct. 23-29, 2014 [Published Las Vegas Review Journal - 2 hours ago]
Platforms Could Be The Next Phase of Civic Tech [Published CivSource - 2 hours ago]
Ironwood Pharmaceuticals’s Neutral Rating Reaff... [Published American Banking News - Forex - 3 hours ago]
A New Drug to Calm Agitation, Uncontrollable La... [Published Alzheimer Research Forum - 3 hours ago]
MorphoSys gets milestone from Novartis; acquire... [Published Pharma Letter - 3 hours ago]
MDA demos tracking, targeting capability of Aegis [Published UPI - 3 hours ago]
Provectus Pharmaceuticals : "Very Impressive Da... [Published 4 Traders - 3 hours ago]
How Has Travel Behavior Changed among North Ame... [Published TickerTech.com - 3 hours ago]
Taylor County Expo Center Details Facility Needs [Published Big Country - 3 hours ago]
WHO begins testing new Ebola treatment [Published WorldNetDaily - 3 hours ago]
Ashley Furniture Completes 1.1 Million Square F... [Published Woodworking Magazine - 4 hours ago]
Council opens budget hearings [Published Steubenville Herald-Star - 4 hours ago]
What Was It Like to Work at the Original Napster? [Published Slate Magazine - 4 hours ago]
True Gold to generate over US$118 million from ... [Published MiningReview.com - 4 hours ago]
Celgene Reports More Good Crohn's Disease Data [Published Investor's Business Daily - 4 hours ago]
HPC in Higher Education [Published HPC Wire - 4 hours ago]
Boehringer Ingelheim initiates global Phase III... [Published PipelineReview - 5 hours ago]
LIGHTBRIDGE : and Canada's Nuclear Science %7E ... [Published 4 Traders - 5 hours ago]
Synairgen PLC's potential is Astra-nomical [Published Proactive Investors.co.uk - 5 hours ago]
Omeros halts a Phase II Huntington's trial over... [Published FierceBiotech - 5 hours ago]
AbbVie's $55B deal for Shire is officially dead... [Published FierceBiotech - 5 hours ago]
Palm Beach Neurological Center participates in ... [Published Scoop Asia - 5 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Unum Therapeutics scores $12 mln Series A [Published PE Hub Blog - 6 hours ago]
Unum Therapeutics has received $12 million in Series A funding. Fidelity Biosciences and Atlas Venture led the round with participation from Sanofi-Genzyme BioVentures . Headquartered in Cambridge, Mass., Unum Therapeutics is developing cellular ...
Viamet Pharma raises $60 mln [Published PE Hub Blog - 8 hours ago]
Viamet Pharmaceuticals Holdings said Tuesday it closed a $60 million Series D financing provided by Brandon Point Industries Ltd. working with Woodford Investment Management . Current investors includes Novartis Venture Fund , Lilly Ventures , ...
True Gold's North Kao Deposit to Generate over ... [Published Marketwire - Breaking News Releases - 9 hours ago]
Phase II Expansion Scenario Adds Average of Approx. 118,000 Ounces Gold per Year for 2.5 Years ...
Hatchtech Announces Successful Results from Pha... [Published EON Science - 15 hours ago]
MELBOURNE, Australia--(EON: Enhanced Online News)--Hatchtech announced positive results from a Phase 2 clinical study evaluating the ovicidal efficacy (ability to kill lice eggs) of a single, 10 minute application of Xeglyze™ Lotion. ...
Hatchtech Announces Successful Results from Pha... [Published Business Wire Health News - 15 hours ago]
MELBOURNE, Australia--(BUSINESS WIRE)--Hatchtech announced positive results from a Phase 2 clinical study evaluating the ovicidal efficacy (ability to kill lice eggs) of a single, 10 minute application of Xeglyze™ Lotion. ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
SOFIE BIOSCIENCES receives $1.5M NCI Phase II SBIR [Published Financial Services - Oct 16 2014]
WholeHealth Products Inc. is extremely pleased ... [Published Financial Services - Oct 14 2014]
Novavax Initiates Phase 2 Clinical Trial of RSV... [Published GlobeNewswire: Acquisitions News - Oct 14 2014]
Ohr Pharmaceutical Announces Successful End of ... [Published GlobeNewswire: Advertising News - Oct 14 2014]
Tekmira's Partner Reports Positive Clinical Dat... [Published GlobeNewswire: Acquisitions News - Oct 14 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.